Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes - Contacts and Locations

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

This study is currently recruiting participants.

Study NCT00338949. Last updated on September 18, 2008. Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00338949

Contacts


Contact: Tanya Baker, BS	858-552-8585 ext 2875	tanyab@ucsd.edu

Contact: Jonathan M. Meyer, MD	858-642-3570	jmmeyer@ucsd.edu

Locations


United States, California
	VA San Diego Healthcare System	Recruiting
	San Diego, California, United States, 92161
	Principal Investigator: Jonathan M. Meyer, MD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Jonathan M. Meyer, MD	University of California, San Diego & VA San Diego Healthcare System